ArticleHLA2023
Software update: Interpreting killer-cell immunoglobulin-like receptors from whole genome sequence data with PING.
Article in HLA, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 3 citations in OpenAlex.
- High KIR diversity in Uganda and Botswana children living with HIV.Human immunology · 2026Article
- Graph-KIR: graph-based KIR copy number estimation and allele calling using short-read sequencing data.Bioinformatics (Oxford, England) · 2026Article
- Article
- Geny: a genotyping tool for allelic decomposition of killer cell immunoglobulin-like receptor genes.Frontiers in immunology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Here, we demonstrate improvements to our bioinformatic pipeline, PING, which provides high-resolution genotyping of killer-cell immunoglobulin-like receptor (KIR) sequencing data, that expand the method to provide KIR interpretation from whole genome sequencing (WGS) data. We evaluated performance using synthetic sequence datasets and real-world data from the 1000 Genomes Project (1KGP). PING demonstrated high exonic genotyping performance on the synthetic sequence dataset meant to approximate real-world data at 95% accuracy (N = 1366). This result was mirrored in the analysis of 1KGP European data (N = 215) with most genes showing near or below 5% frequency of unresolved exonic genotypes, which is an important indicator for genotyping errors in real-world data. An analysis into the distributions of genotyping errors for the synthetic sequence datasets gave insights into how to further improve genotype accuracy. Similarly, an analysis into ambiguous exonic genotype frequencies for the 1KGP European data, which showed high rates of unresolved genotypes, highlighted that an effective phasing method will be an impactful future additional to the PING workflow. Together, these results demonstrate that PING can effectively provide high-resolution KIR genotyping on WGS data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.